Palliative Care in Non-Cancer Conditions — MCQs
In a patient with COPD, what is the best management option?
A 45-year-old female presents with dyspnea, orthopnea, and bilateral leg edema. Echo shows EF 35%. BNP 850 pg/mL. Which drug class has shown mortality benefit in this condition?
Elisabeth Kübler-Ross proposed five stages of:
SPIKES protocol is used for:
A 45-year-old male presents with progressive dyspnea, orthopnea, and paroxysmal nocturnal dyspnea. His echocardiogram shows reduced ejection fraction and pulmonary congestion. What is the most appropriate management?
What is the primary cause of death in Neuroleptic Malignant Syndrome?
A 40-year-old male presents with sudden onset breathlessness, anxiety, palpitations, hot flushes, dizziness, and chest pain. He is afraid of dying. Physical examination is normal, and ECG and X-ray findings are also normal. What is the diagnosis?
A 35 year old man feels that he is about to die because he is suffering from gastric cancer. All his radiological investigations prove the contrary. Which is the most probable diagnosis?
At what glomerular filtration rate (GFR) is the term "end-stage renal disease (ESRD)" typically classified?
A 60-year-old male patient has an antral carcinoma spreading to the head of the pancreas with multiple small metastases to the right lobe of the liver. What is the best treatment approach?
Palliative Care in Non-Cancer Conditions Indian Medical PG Practice Questions and MCQs
Question 1: In a patient with COPD, what is the best management option?
- A. Quit smoking (Correct Answer)
- B. Bronchodilators
- C. Low flow oxygen
- D. Mucolytics
Explanation: ***Quit smoking*** - **Smoking cessation** is the single most effective intervention for slowing the progression of **COPD** and improving lung function [1]. - It reduces exacerbation rates and improves overall mortality, making it the cornerstone of management [1]. *Bronchodilators* - **Bronchodilators** (e.g., beta-agonists, anticholinergics) are crucial for symptomatic relief by opening airways, but they do not alter the disease progression [1]. - While essential for managing symptoms, they are not the "best" in terms of modifying the disease course. *Low flow oxygen* - **Oxygen therapy** is indicated for patients with **severe hypoxemia** (PaO2 < 55 mmHg or SaO2 < 88%) to improve survival and quality of life [2]. - It is a supportive treatment for advanced disease and does not prevent or slow the progression of COPD itself. *Mucolytics* - **Mucolytics** may be used in some patients with COPD and chronic productive cough to reduce sputum viscosity and improve clearance. - Their benefit is primarily symptomatic, and they do not have a significant impact on disease progression or mortality.
Question 2: A 45-year-old female presents with dyspnea, orthopnea, and bilateral leg edema. Echo shows EF 35%. BNP 850 pg/mL. Which drug class has shown mortality benefit in this condition?
- A. Calcium channel blockers
- B. Alpha blockers
- C. Nitrates
- D. Beta blockers (Correct Answer)
Explanation: ***Beta blockers*** - In **heart failure with reduced ejection fraction (HFrEF)**, beta blockers (e.g., carvedilol, metoprolol succinate, bisoprolol) significantly reduce **mortality** and hospitalizations [1]. - They work by blocking the adverse effects of **sympathetic nervous system activation** on the heart, improving cardiac remodeling and function over time. *Calcium channel blockers* - Non-dihydropyridine calcium channel blockers (e.g., verapamil, diltiazem) generally have **negative inotropic effects** and can worsen outcomes in HFrEF. - While some dihydropyridine calcium channel blockers (e.g., amlodipine) are considered safe, they do **not confer a mortality benefit** in this condition. *Alpha blockers* - Alpha blockers like prazosin are primarily used for **hypertension** and **benign prostatic hyperplasia**. - They have **not shown mortality benefit** in heart failure and may even cause symptomatic **hypotension**. *Nitrates* - Nitrates (e.g., isosorbide dinitrate, nitroglycerin) are effective **vasodilators** that reduce preload and afterload, alleviating symptoms like dyspnea [1]. - However, they do not consistently **reduce mortality** when used alone in HFrEF and are often combined with hydralazine for specific populations (e.g., African Americans).
Question 3: Elisabeth Kübler-Ross proposed five stages of:
- A. Grief (Correct Answer)
- B. Delusion
- C. Schizophrenia
- D. None of the options
Explanation: ***Grief*** - Elisabeth Kübler-Ross is renowned for her work on the **five stages of grief**, a model describing emotional responses to terminal illness or significant loss. - These stages are **denial, anger, bargaining, depression, and acceptance**, which individuals may experience when facing their own death or the death of a loved one. - This model was introduced in her seminal 1969 book **"On Death and Dying"**. *Delusion* - Delusions are **fixed, false beliefs** that are not in keeping with the individual's cultural background, often seen in psychotic disorders like schizophrenia. - Kübler-Ross's work does not focus on specific cognitive distortions like delusions. *Schizophrenia* - Schizophrenia is a severe psychiatric disorder characterized by **distortions of thought, perception, emotions, language, sense of self, and behavior**. - While schizophrenia can involve significant psychological distress, it is a **distinct clinical entity** not directly related to Kübler-Ross's stages of grief. *None of the options* - This option is incorrect because the work of Elisabeth Kübler-Ross is directly associated with the **five stages of grief**, which describe the emotional process individuals experience when facing terminal illness or loss.
Question 4: SPIKES protocol is used for:
- A. RCT
- B. Triage
- C. Communication with patients/attendants regarding bad news (Correct Answer)
- D. Writing death certificate
Explanation: ***Communication with patients/attendants regarding bad news*** - The **SPIKES protocol** provides a structured framework for delivering difficult or "bad" news sensitively and effectively to patients and their families. - It ensures that the communication is **patient-centered**, empathetic, and allows for understanding and emotional support. *RCT* - **Randomized Controlled Trials (RCTs)** are study designs used to evaluate the efficacy and safety of medical interventions. - They involve randomizing participants to different treatment groups and are not related to breaking bad news. *Triage* - **Triage** is the process of prioritizing patients based on the severity of their condition, typically used in emergency settings. - Its purpose is to allocate resources efficiently and save lives, not to guide difficult conversations. *Writing death certificate* - **Writing a death certificate** is a legal and administrative task that involves documenting the cause and circumstances of a person's death. - While it follows a death, the SPIKES protocol is for the *process of conveying* difficult news, such as a terminal diagnosis or death, rather than the administrative task afterward.
Question 5: A 45-year-old male presents with progressive dyspnea, orthopnea, and paroxysmal nocturnal dyspnea. His echocardiogram shows reduced ejection fraction and pulmonary congestion. What is the most appropriate management?
- A. Inhaled corticosteroids
- B. IV antibiotics
- C. IV diuretics and nitrates (Correct Answer)
- D. Thoracentesis
Explanation: The patient's symptoms (dyspnea, orthopnea, PND) and echocardiogram findings (reduced ejection fraction, **pulmonary congestion**) are classic for **acute decompensated heart failure** [1]. - **IV diuretics** (e.g., furosemide) help reduce **preload** and alleviate pulmonary congestion, while **nitrates** (e.g., nitroglycerin) reduce both **preload and afterload**, improving cardiac output and symptoms [1]. *Inhaled corticosteroids* - These are primarily used for managing **inflammatory airway diseases** like **asthma** or COPD. - They would not address the underlying **cardiac pathology** or acute pulmonary congestion in heart failure. *IV antibiotics* - Antibiotics are indicated for **bacterial infections**, which are not suggested by the clinical presentation of progressive dyspnea and isolated cardiac dysfunction. - Giving antibiotics without evidence of infection would be inappropriate and could contribute to **antibiotic resistance**. *Thoracentesis* - Thoracentesis is a procedure to remove fluid from the **pleural space**. While pulmonary congestion and heart failure can lead to **pleural effusions**, it's usually not the first-line management for acute heart failure symptoms. - The primary treatment focuses on reducing **intravascular volume** and improving cardiac function, which would often resolve effusions without the need for an invasive procedure.
Question 6: What is the primary cause of death in Neuroleptic Malignant Syndrome?
- A. Respiratory failure
- B. Liver failure
- C. None of the options (Correct Answer)
- D. Drug toxicity
Explanation: ***None of the options*** - The **primary cause of death** in Neuroleptic Malignant Syndrome is **renal failure secondary to rhabdomyolysis**, which is not listed among the options. - **Severe muscle rigidity** in NMS leads to massive muscle breakdown (rhabdomyolysis) → release of myoglobin → myoglobinuria → acute tubular necrosis → acute renal failure. - Mortality in NMS ranges from **10-20%**, with renal complications being the leading cause of death. - Other significant causes include **cardiovascular collapse, arrhythmias, DIC**, and **respiratory complications**, but renal failure remains the most common fatal outcome. *Respiratory failure* - While respiratory complications occur in NMS (aspiration pneumonia, respiratory muscle rigidity), this is **not the primary cause of death**. - Respiratory failure can contribute to mortality but is typically **secondary** to other complications or occurs less frequently than renal failure as the direct cause. - It is a serious complication but not the most common fatal outcome. *Liver failure* - **Hepatotoxicity** is not a characteristic feature or primary cause of death in NMS. - Though elevated liver enzymes may occur, liver failure is **not a typical cause of mortality** in NMS. - The pathophysiology centers on **dopamine blockade**, autonomic instability, and muscle breakdown, not hepatic dysfunction. *Drug toxicity* - NMS is an **idiosyncratic reaction** to dopamine antagonists (typical and atypical antipsychotics), not a dose-dependent toxic effect. - Death results from the **physiological complications of the syndrome** (renal failure, cardiovascular collapse, hyperthermia), not from direct drug toxicity or overdose. - The mechanism is related to dopamine receptor blockade and subsequent dysregulation, not toxic poisoning.
Question 7: A 40-year-old male presents with sudden onset breathlessness, anxiety, palpitations, hot flushes, dizziness, and chest pain. He is afraid of dying. Physical examination is normal, and ECG and X-ray findings are also normal. What is the diagnosis?
- A. Panic attack (Correct Answer)
- B. Acute psychosis
- C. Generalized anxiety disorder
- D. Factitious disorder
Explanation: ***Panic attack*** - The sudden onset of intense fear or discomfort, accompanied by a cluster of physical symptoms such as **breathlessness**, **palpitations**, **chest pain**, and a **fear of dying**, is characteristic of a panic attack. - The **normal physical examination**, **ECG**, and **X-ray findings** rule out organic causes, supporting a psychiatric diagnosis. *Generalized anxiety disorder* - Characterized by **persistent and excessive worry** about various daily life events, rather than discrete, intense episodes of fear. - While it can manifest with physical symptoms like fatigue or muscle tension, it typically lacks the **sudden, overwhelming nature** and **fear of dying** seen in panic attacks. *Factitious disorder* - Involves **intentional falsification or induction of physical or psychological symptoms** without obvious external rewards. - This patient's symptoms are presented as genuine and distressing, not as a deliberate fabrication for secondary gain. *Acute psychosis* - Characterized by a **marked impairment in reality testing**, often involving **hallucinations**, **delusions**, or disorganized thought and speech. - The patient's symptoms are primarily anxiety-related and physical, with no mention of such psychotic features.
Question 8: A 35 year old man feels that he is about to die because he is suffering from gastric cancer. All his radiological investigations prove the contrary. Which is the most probable diagnosis?
- A. Somatic symptom disorder
- B. Conversion disorder
- C. Delusional disorder
- D. Illness anxiety disorder (Correct Answer)
Explanation: ***Illness anxiety disorder*** - This patient exhibits a **preoccupation with having a serious illness** (gastric cancer) despite evidence to the contrary (negative radiological investigations). - The fear of illness is **persistent** and **causes significant distress**, leading to the belief that he is "about to die." - In illness anxiety disorder, patients may have **intense health anxiety** but typically retain some capacity for at least temporary reassurance with negative test results, even if the anxiety returns. - The presentation focuses on **fear and preoccupation** rather than an absolutely fixed, unshakeable delusional belief. *Somatic symptom disorder* - Characterized by **one or more significant physical symptoms** that cause significant distress or functional impairment, along with excessive thoughts, feelings, or behaviors related to these symptoms. - In this case, the primary concern is the *fear* of having a serious illness, rather than significant physical symptoms themselves. - The emphasis is on the **belief about having cancer** rather than distressing somatic symptoms. *Conversion disorder* - Involves **neurological symptoms** (e.g., altered motor or sensory function, weakness, paralysis, seizures) that are incompatible with recognized neurological or medical conditions. - The patient's presentation does not involve neurological deficits, and the primary concern is fear of a specific disease (gastric cancer) rather than unexplained neurological symptoms. *Delusional disorder* - Characterized by one or more **fixed, unshakeable, nonbizarre delusions** that persist for at least one month. - In **delusional disorder, somatic type**, the patient would have an absolutely fixed belief about having a disease with **no insight** and **no response to reassurance** despite clear contrary evidence. - While this patient has a strong belief about having cancer, the clinical presentation described (preoccupation with health concerns in the context of negative investigations) aligns more specifically with **illness anxiety disorder**, which is the more common diagnosis in this scenario per standard medical teaching.
Question 9: At what glomerular filtration rate (GFR) is the term "end-stage renal disease (ESRD)" typically classified?
- A. less than 15% of normal (Correct Answer)
- B. 10%—25% of normal
- C. 15%—25% of normal
- D. 5%—10% of normal
Explanation: ***Less than 15% of normal*** - **End-stage renal disease (ESRD)** is defined by a **glomerular filtration rate (GFR)** that falls below **15 mL/min/1.73 m²**, which is approximately **less than 15% of normal function**. - At this stage, **renal replacement therapy** (dialysis or transplantation) is typically required to sustain life. *15%—25% of normal* - This GFR range (15-25 mL/min/1.73 m²) corresponds to **Stage 4 chronic kidney disease (CKD)**, which is severe but not yet formally "end-stage." - Patients in this stage require careful monitoring and management, but may not immediately need renal replacement therapy. *10%—25% of normal* - This range overlaps with both **severe CKD (Stage 4)** and the beginning of **ESRD (Stage 5)**, but it is not the precise definition for ESRD. - The critical threshold for ESRD is uniformly established as GFR below 15 mL/min/1.73 m². *5%—10% of normal* - While a GFR in this range certainly indicates **ESRD**, the official classification includes any GFR **below 15% of normal** (or below 15 mL/min/1.73 m²), making "less than 15%" the most accurate and inclusive answer. - This smaller range describes a more advanced state within ESRD, but not the general definition.
Question 10: A 60-year-old male patient has an antral carcinoma spreading to the head of the pancreas with multiple small metastases to the right lobe of the liver. What is the best treatment approach?
- A. Surgical resection with adjuvant chemotherapy
- B. Radiation therapy alone
- C. Palliative chemotherapy (Correct Answer)
- D. Supportive care only
Explanation: Palliative chemotherapy - The presence of **multiple small metastases** in the liver indicates **metastatic disease**, which is generally considered incurable with surgery [2]. - **Palliative chemotherapy** aims to control disease progression, alleviate symptoms, and improve quality of life in patients with advanced metastatic cancer. Surgical resection with adjuvant chemotherapy - **Surgical resection** is not indicated due to the presence of **distant metastases** (to the liver), classifying the disease as Stage IV [1]. - **Adjuvant chemotherapy** is given after curative surgery to reduce recurrence risk, which is not the goal here as the disease is already metastatic. Radiation therapy alone - **Radiation therapy alone** is typically reserved for localized disease or for palliative symptom management (e.g., pain from bone metastases), not for widespread metastatic disease. - It would not adequately address the systemic nature of **multiple liver metastases** from a pancreatic primary. Supportive care only - While supportive care is crucial, **palliative chemotherapy** offers a chance to prolong survival and manage symptoms more effectively than supportive care alone in suitable patients with advanced pancreatic cancer. - Skipping chemotherapy entirely would mean foregoing potential benefits in terms of disease control and quality of life, especially for patients with a good performance status.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free